SCHEMBL3786171

SCHEMBL3786171

Cc1cc(NN)cc(C)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.43
NPC1 O15118 2/20 0.43
ALDH1A1 P00352 3/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 1/20 0.39
PRKCI P41743 1/20 0.39
NOS3 P29474 2/20 0.39
NOS2 P35228 2/20 0.39
NOS1 P29475 1/20 0.39
POLB P06746 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
CYP1A2 P05177 3/20 0.35
CYP2D6 P10635 2/20 0.35
NQO2 P16083 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
LMNA P02545 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2C19 P33261 2/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL694450 0.97 NPC1 (0.42) GAANPC1ALDH1A1MAPTKDM4E
SCHEMBL20850145 0.77 MAPT (0.41) NPC1MAPTPRKCINOS3NOS2
SCHEMBL883719 0.74 NOS3 (0.48) GAAALDH1A1MAPTPRKCINOS3
Hydrochloric Acid SCHEMBL28374836 0.72 NOS3 (0.46) GAANPC1ALDH1A1MAPTPRKCI
SCHEMBL949243 0.72 GAA (0.45) GAANPC1ALDH1A1MAPTKDM4E
Hydrochloric Acid SCHEMBL28375230 0.72 NOS3 (0.46) GAANPC1ALDH1A1MAPTPRKCI
SCHEMBL486140 0.71 MAPT (0.50) GAANPC1ALDH1A1MAPTCYP1A2
SCHEMBL22423660 0.71 CYP3A4 (0.36) GAAALDH1A1MAPTNOS3NOS2
SCHEMBL2476869 0.70
SCHEMBL11719322 0.70 ACP1 (0.41) ALDH1A1MAPTCYP1A2CYP2D6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8778974-B2 Trisubstituted 1,2,4 triazoles JANSSEN PHARMACEUTICA NV (BE) 2014-07-15 US disclosed
US-20100324053-A1 TRISUBSTITUTED 1,2,4 TRIAZOLES JANSSEN PHARMACEUTICA NV (BE) 2010-12-23 US disclosed
US-4698344-A LIPOXYGENASE INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 1987-10-06 US disclosed
US-4663327-A MICROBIOCIDES, FUNGICIDES BAYER AKTIENGESELLSCHAFT (DE) 1987-05-05 US disclosed
US-3936444-A FROM A LACTIM-ETHER AND AN ARYL OR HETEROARYL HYDRAZINE, ACID CATALYST BAYER AKTIENGESELLSCHAFT (DT) 1976-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100324053-A1 TRISUBSTITUTED 1,2,4 TRIAZOLES CHRNA1, CHRNA5, CHRNE GAA 3536/4885NPC1 2198/4885ALDH1A1 1718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.